137 related articles for article (PubMed ID: 9846027)
21. Early conversion from oral morphine to transdermal fentanyl in patients with cancer pain.
Tani M; Fuku A; Terashita S; Kashiwagi H; Yukawa H; Yamaue H
Hepatogastroenterology; 2008; 55(86-87):1545-8. PubMed ID: 19102339
[TBL] [Abstract][Full Text] [Related]
22. Breakthrough strong opioid analgesia prescription in patients using transdermal fentanyl admitted to a hospice.
Lawrie I; Lloyd-Williams M; Waterhouse E
Am J Hosp Palliat Care; 2003; 20(3):229-30. PubMed ID: 12785045
[TBL] [Abstract][Full Text] [Related]
23. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
24. Transdermal fentanyl in the long-term treatment of cancer pain: a prospective study of 50 patients with advanced cancer of the gastrointestinal tract or the head and neck region.
Grond S; Zech D; Lehmann KA; Radbruch L; Breitenbach H; Hertel D
Pain; 1997 Jan; 69(1-2):191-8. PubMed ID: 9060030
[TBL] [Abstract][Full Text] [Related]
25. From codeine to transdermal fentanyl for cancer pain control: a safety and efficacy clinical trial.
Mystakidou K; Befon S; Kouskouni E; Gerolymatos K; Georgaki S; Tsilika E; Vlahos L
Anticancer Res; 2001; 21(3C):2225-30. PubMed ID: 11501851
[TBL] [Abstract][Full Text] [Related]
26. Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics.
Mystakidou K; Katsouda E; Parpa E; Tsiatas ML; Vlahos L
Am J Hosp Palliat Care; 2005; 22(3):228-32. PubMed ID: 15909786
[TBL] [Abstract][Full Text] [Related]
27. [The opioid combination of transdermal fentanyl and sustained release morphine for refractory cancer pain--a case report].
Shinjo T; Okada M
Gan To Kagaku Ryoho; 2005 Nov; 32(12):1997-2000. PubMed ID: 16282744
[TBL] [Abstract][Full Text] [Related]
28. Care of the dying: is pain control compromised or enhanced by continuation of the fentanyl transdermal patch in the dying phase?
Ellershaw JE; Kinder C; Aldridge J; Allison M; Smith JC
J Pain Symptom Manage; 2002 Oct; 24(4):398-403. PubMed ID: 12505208
[TBL] [Abstract][Full Text] [Related]
29. Treatment of severe cancer pain by transdermal fentanyl.
Ljuca D; Husić S
Bosn J Basic Med Sci; 2010 May; 10(2):158-64. PubMed ID: 20507298
[TBL] [Abstract][Full Text] [Related]
30. Day-to-day titration to initiate transdermal fentanyl in patients with cancer pain: short- and long-term experiences in a prospective study of 39 patients.
Korte W; de Stoutz N; Morant R
J Pain Symptom Manage; 1996 Mar; 11(3):139-46. PubMed ID: 8851370
[TBL] [Abstract][Full Text] [Related]
31. Transdermal fentanyl for chronic pain in AIDS: a pilot study.
Newshan G; Lefkowitz M
J Pain Symptom Manage; 2001 Jan; 21(1):69-77. PubMed ID: 11223316
[TBL] [Abstract][Full Text] [Related]
32. Comparison of oral controlled-release morphine with transdermal fentanyl in terminal cancer pain.
Wong JO; Chiu GL; Tsao CJ; Chang CL
Acta Anaesthesiol Sin; 1997 Mar; 35(1):25-32. PubMed ID: 9212478
[TBL] [Abstract][Full Text] [Related]
33. [A case of long-term, high-dose transdermal fentanyl application for lung cancer pain].
Kamiya N; Yasogawa Y; Nishi Y; Takahashi Y; Kondo Y; Hirai T; Sakurai M; Masumizu K; Onosato W; Koyama T
Gan To Kagaku Ryoho; 2006 Mar; 33(3):377-80. PubMed ID: 16531723
[TBL] [Abstract][Full Text] [Related]
34. Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study.
Portenoy RK; Payne R; Coluzzi P; Raschko JW; Lyss A; Busch MA; Frigerio V; Ingham J; Loseth DB; Nordbrock E; Rhiner M
Pain; 1999 Feb; 79(2-3):303-12. PubMed ID: 10068176
[TBL] [Abstract][Full Text] [Related]
35. How should we use transdermal fentanyl (TF) for pain management in palliative care patients?
Fainsinger RL; Bruera E
J Palliat Care; 1996; 12(1):48-53. PubMed ID: 8857249
[No Abstract] [Full Text] [Related]
36. Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR).
Coluzzi PH; Schwartzberg L; Conroy JD; Charapata S; Gay M; Busch MA; Chavez J; Ashley J; Lebo D; McCracken M; Portenoy RK
Pain; 2001 Mar; 91(1-2):123-30. PubMed ID: 11240084
[TBL] [Abstract][Full Text] [Related]
37. Capsules and suppositories of methadone for patients on high-dose opioids for cancer pain: clinical and economic considerations.
Watanabe S; Belzile M; Kuehn N; Hanson J; Bruera E
Cancer Treat Rev; 1996 Jan; 22 Suppl A():131-6. PubMed ID: 8625339
[TBL] [Abstract][Full Text] [Related]
38. [Transdermal fentanyl for neuropathic pain: a case report].
Tuncer S; Reisli R; Kara I; Otelcioğlu S
Agri; 2006 Oct; 18(4):31-5. PubMed ID: 17457711
[TBL] [Abstract][Full Text] [Related]
39. Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control.
Jeal W; Benfield P
Drugs; 1997 Jan; 53(1):109-38. PubMed ID: 9010652
[TBL] [Abstract][Full Text] [Related]
40. A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioids.
Enting RH; Oldenmenger WH; van der Rijt CC; Wilms EB; Elfrink EJ; Elswijk I; Sillevis Smitt PA
Cancer; 2002 Jun; 94(11):3049-56. PubMed ID: 12115396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
